PC(20:5/0:0)
|
Basic information |
| Metabolite name | PC(20:5/0:0) |
 | N/A |
 |
C00157 |
 |
N/A |
| Synonyms | NA |
| No. of studies | 2 |
|
Basic information |
| Metabolite name | PC(20:5/0:0) |
| N/A |
|
C00157 |
|
N/A |
| Synonyms | NA |
| No. of studies | 2 |
|
Relationship between PC(20:5/0:0) and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1024 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Down |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | Serum | ICR mouse | Up |
| Study M464 | Type1 | drug-naive MDD group vs. control group | Plasma | Human | Up |
| Study M464 | Type1 | drug-treatment MDD group vs. control group | Plasma | Human | Up |